179 related articles for article (PubMed ID: 9469636)
1. Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction.
Ito K; Zhu YZ; Zhu YC; Gohlke P; Unger T
Jpn J Pharmacol; 1997 Dec; 75(4):311-8. PubMed ID: 9469636
[TBL] [Abstract][Full Text] [Related]
2. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
Black MJ; Bertram JF; Johnston CI
J Hypertens; 2001 Apr; 19(4):785-94. PubMed ID: 11330882
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction.
Dumoulin MJ; Adam A; Rouleau JL; Gosselin H; Lamontagne D
Can J Physiol Pharmacol; 2003 Jul; 81(7):740-6. PubMed ID: 12897822
[TBL] [Abstract][Full Text] [Related]
8. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
[TBL] [Abstract][Full Text] [Related]
9. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.
Tschöpe C; Gohlke P; Zhu YZ; Linz W; Schölkens B; Unger T
J Card Fail; 1997 Jun; 3(2):133-48. PubMed ID: 9220313
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
Duncan AM; Burrell LM; Kladis A; Campbell DJ
J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
Gohlke P; Kuwer I; Bartenbach S; Schnell A; Unger T
J Cardiovasc Pharmacol; 1994 Sep; 24(3):462-9. PubMed ID: 7528303
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
14. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Pu Q; Larouche I; Schiffrin EL
Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
[TBL] [Abstract][Full Text] [Related]
15. Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin.
Gohlke P; Unger T
Am J Cardiol; 1995 Nov; 76(15):41E-45E. PubMed ID: 7484888
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
[TBL] [Abstract][Full Text] [Related]
17. Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.
Zhu YC; Stauss HM; Bao G; Gohlke P; Zhu YZ; Redlich T; Unger T
Can J Physiol Pharmacol; 1995 Jul; 73(7):827-31. PubMed ID: 8846416
[TBL] [Abstract][Full Text] [Related]
18. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
19. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
Campbell DJ
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
